Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/05/1993 | WO1993015083A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them |
08/05/1993 | WO1993015080A1 Azabicyclo compounds as calcium channel antagonists |
08/05/1993 | WO1993015079A1 Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors |
08/05/1993 | WO1993015078A1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
08/05/1993 | WO1993015073A1 Azabricyclic compounds as calcium channel antagonists |
08/05/1993 | WO1993015072A1 Antibacterial 1-normon-2-yl thiazolyl ketones |
08/05/1993 | WO1993015071A1 Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors |
08/05/1993 | WO1993015068A1 Novel benzopyran derivative |
08/05/1993 | WO1993015067A1 Benzopyran and related ltb4 antagonists |
08/05/1993 | WO1993015066A1 Benzopyran and related ltb4 antagonists |
08/05/1993 | WO1993015062A1 Opioid diarylmethylpiperazines and piperidines |
08/05/1993 | WO1993015061A2 Method of preparing 2-arylbenzimidazole 5-sulphonic acids |
08/05/1993 | WO1993015059A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists |
08/05/1993 | WO1993015058A1 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
08/05/1993 | WO1993015057A1 Pyridinecarboximidamide compound and use thereof |
08/05/1993 | WO1993015056A1 Pyridone derivatives, their preparation and use as medicines |
08/05/1993 | WO1993015055A1 Pyridine derivatives, their preparation and use as medicines |
08/05/1993 | WO1993015052A1 Compounds as calcium channel antagonists |
08/05/1993 | WO1993015051A1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors |
08/05/1993 | WO1993015041A1 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
08/05/1993 | WO1993014787A1 Taxol as a radiation sensitizer |
08/05/1993 | WO1993014780A1 The use of a compound for the manufacture of a medicament for the treatment of hiv infection |
08/05/1993 | WO1993014772A1 Utilization of niobium derivatives as active principle of medicaments useful in the treatment and/or prevention of glucid and/or lipid metabolium troubles |
08/05/1993 | WO1993014771A1 Macrocyclic compounds in the prophylactic treatment of aids |
08/05/1993 | WO1993014770A1 Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative |
08/05/1993 | WO1993014769A1 Method for making universal donor cells |
08/05/1993 | WO1993014767A2 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
08/05/1993 | WO1993014766A1 Use of n-acetyl glucosamine for the treatment of food allergy |
08/05/1993 | WO1993014765A1 Use of n-acetyl glucosamine for treating lower gastrointestinal tract disorders |
08/05/1993 | WO1993014764A1 Treatment of low pressure glaucoma and ischemic retinal degeneration with metoclopramide |
08/05/1993 | WO1993014763A1 1α-HYDROXY-24-EPI-VITAMIN D¿4? |
08/05/1993 | WO1993014762A1 17β-HYDROXYBENZOYL-4-AZA-5α-ANDROST-1-EN-3-ONES USEFUL TO TREAT BALDNESS |
08/05/1993 | WO1993014761A1 Prostacyclin and carbacyclin derivatives as agents in the treatment of multiple sclerosis |
08/05/1993 | WO1993014760A2 Methods |
08/05/1993 | WO1993014759A1 Treatment of low pressure glaucoma and ischemic retinal degeneration with loxapine |
08/05/1993 | WO1993014758A1 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses |
08/05/1993 | WO1993014757A1 Treatment of low pressure glaucoma and ischemic retinal degeneration with droperidol |
08/05/1993 | WO1993014755A1 Histamine derivatives and methods for their use as immunomodulators |
08/05/1993 | WO1993014754A1 Histamine derivatives and methods for their use as immunomodulators |
08/05/1993 | WO1993014753A1 Histamine derivatives and methods for their use |
08/05/1993 | WO1993014752A1 M. fermentans infection treatment |
08/05/1993 | WO1993014751A1 Pharmaceutical compositions containing as active principle associations of vanadium and/or niobium with pyrocatechol derivatives |
08/05/1993 | WO1993014750A2 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
08/05/1993 | WO1993014749A1 Inhibition of respiratory burst using posttranslational modification inhibitors |
08/05/1993 | WO1993014747A1 Spray-chilled nabumetone |
08/05/1993 | WO1993014746A1 Method and compositions for inhibiting tumor cell metabolism |
08/05/1993 | WO1993014745A1 Use of 5-ht4 receptor antagonists as medicaments for treating migraine |
08/05/1993 | WO1993014743A2 Polar c-1 esters of prostaglandins |
08/05/1993 | WO1993014727A1 Transdermal administration of buprenorphine in the form of ion pair complexes |
08/05/1993 | WO1993014639A1 Method for modulating immune responses in invertebrates |
08/05/1993 | WO1993014629A1 Gene transfer in birds by introduction of dna into muscle in ovo |
08/05/1993 | WO1993012781A3 Creatine analogs having antiviral activity |
08/05/1993 | WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
08/05/1993 | CA2129120A1 1.alpha.-hydroxy-24-epi-vitamin d4 |
08/05/1993 | CA2129119A1 Nucleozymes |
08/05/1993 | CA2129028A1 Prostacyclin and carbacyclin derivatives as agents in the treatment of multiple sclerosis |
08/05/1993 | CA2129027A1 Spray-chilled nabumetone |
08/05/1993 | CA2128896A1 Hepatitis therapeutics |
08/05/1993 | CA2128860A1 Novel steroid intermediates and processes for their preparation |
08/05/1993 | CA2128790A1 Use of a compound for the manufacture of a medicament for the treatment of hiv infection |
08/05/1993 | CA2128779A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them |
08/05/1993 | CA2128699A1 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses |
08/05/1993 | CA2128693A1 Taxol as a radiation sensitizer |
08/05/1993 | CA2128603A1 Novel benzopyran derivatives |
08/05/1993 | CA2128536A1 Azabicyclo compounds as calcium channel antagonists |
08/05/1993 | CA2128535A1 A method for delaying hiv induced aids by administration of substituted azaperane compounds |
08/05/1993 | CA2128516A1 Histamine derivatives and methods for their use as immunomodulators |
08/05/1993 | CA2127689A1 Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors |
08/05/1993 | CA2126692A1 Method for making universal donor cells |
08/05/1993 | CA2125690A1 Antiparasitic agents |
08/05/1993 | CA2117429A1 Gene transfer in birds by introduction of dna into muscle in ovo |
08/05/1993 | CA2117428A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
08/05/1993 | CA2117367A1 3-phenylureido-azepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists |
08/05/1993 | CA2107566A1 Ethanolamine derivatives having sympathomimetic and anti-pollakiuria activities |
08/05/1993 | CA2107348A1 N-sulfonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors |
08/04/1993 | WO1993014748A1 Remedy for dermatopathy and metallothionein inducer |
08/04/1993 | EP0554213A1 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
08/04/1993 | EP0554107A1 Substituted triazoles as angiotensin II inhibitors |
08/04/1993 | EP0554032A2 Bicyclic suflur-containing compounds for the treatment of diseases coursed by immune system disorders compounds |
08/04/1993 | EP0554029A1 Oral compositions |
08/04/1993 | EP0554025A2 Fluorinated cyclobutyl purines and pyrimidines |
08/04/1993 | EP0554004A2 Cephem compounds and antibacterial agents |
08/04/1993 | EP0553890A1 Diphenyl heteroalkyl derivatives, their preparation, as well as medicinal and cosmetic preparations prepared therefrom |
08/04/1993 | EP0553884A1 Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
08/04/1993 | EP0553792A2 Process for the preparation of the disodium salt hemiheptahydrate of ceftriaxone |
08/04/1993 | EP0553790A1 Cyclic amp derivative-containing ointment |
08/04/1993 | EP0553786A2 Salts of glucopyranose derivative and its intermediate |
08/04/1993 | EP0553682A1 Imidazo 4,5-b pyridine derivatives as Angiotensin II antagonists |
08/04/1993 | EP0553658A2 Pharmaceutically active composition from Tanacetum partenium, process of extraction and medicinal composition |
08/04/1993 | EP0553351A1 CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON |
08/04/1993 | EP0553272A1 Synthetic lung surfactant |
08/04/1993 | EP0553263A1 1'-aminospiro-[isoquinoline-4(1h),3'-pyrrolidine]- 1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors in vivo |
08/04/1993 | EP0553253A1 Proanthocyanidin polymers having antiviral activity and methods of obtaining same |
08/04/1993 | EP0553235A1 Targeting viruses and cells for selective internalization by cells |
08/04/1993 | EP0553218A1 Indole derivatives |
08/04/1993 | EP0553194A1 Effective solid non-lozenge anti-acid/anti-gas medicament |
08/04/1993 | EP0553174A1 Arylpyridazinones |
08/04/1993 | EP0553160A1 USE OF ENDO-N-(8-METHYL-8-AZABICYCLO 3.2.1]oct-3-yl)-2,3-DIHYDRO-3,3DIMETHYLINDOLE-1-CARBOXAMIDE IN THE TREATMENT OF DEPENDENCE AND WITHDRAWAL SYNDROME |
08/04/1993 | EP0553156A1 Chromans and thiochromans with retinoid-like activity |
08/04/1993 | EP0553107A1 Protein kinase c modulators with anti-inflammatory and antiviral activity |